NCT00561119 - Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer | Biotech Hunter

Enrollment

326

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Advanced Breast Cancer

Interventions

DRUG

gemcitabine , paclitaxel

"Gemcitabine 1250 mg/m2 i.v. Day 1 \& 8~Paclitaxel 175 mg/m2 i.v. day 1~repeat every 3 weeks"

Trial Locations (15)

Unknown

Ajou University University Hospital, Suwon

Yeungnam University Hospital, Kyungsan

Asan Medical Center, Seoul

Soonchunhyang University Hospital, Seoul

431-070

Hanlym University Hospital, Anyang

463-707

Bundang Seoul National University Hospital, Bundang

701-600

Daegu Patima Hospital, Daegu

400-711

Inha University School of Medicine, Inchon

110-744

Seoul National University Hospital, Seoul

120-752

Yonsei University Hospital, Seoul

135-710

Samsung Medical Center, Seoul

140-320

National Cancer Center, Seoul

143-729

Kunkuk University Hospital, Seoul

911-1

Ewha University Hospital, Seoul

682-714

Ulsan University Hospital, Ulsan

All Listed Sponsors

collaborator

Korean Cancer Study Group

OTHER

lead

Samsung Medical Center

OTHER